Biomedica Immunoassays

495 €

Contact us!

MDA-oxLDL ELISA

High specificity of the antibodies to MDA-adducts.

PRODUCT DETAILS

Assay characteristics:

Cat.No.: BI-20022
Method: Sandwich ELISA, HRP/TMB, 12x8-well strips
Sample type:Serum, plasma (EDTA, heparin, citrate)
Standard range:0-10 µg/ml (6 serum based standards) 
Standard points:0/0.6/1.25/2.5/5/10 µg/ml
Control:1 serum based control
Sample size:20 µl / well
Incubation time:1.5 h / 1.5 h / 30 min

Sensitivity:
LOD: 0.05 µg/ml (0 µg/ml + 3 SD)

Precision:
Intra-assay (n=3) ≤ 8%, Inter-assay (n=4) ≤ 7%

Values from apparently healthy individuals:
Median (serum, n=50): 263 mU/ml.
It is recommended to establish the normal range for each laboratory.   

Principle of the assay: 
 


Manual ELISAs - easily adaptable for automation! 

Back to top

INSTRUCTIONS FOR USE

Click here for IFU.

Back to top

ADDITIONAL INFORMATION

Oxidatively modified lipoproteins (oxLDLs) play an important role in the progression of atherosclerosis and coronary artery disease. Low-density lipoprotein (LDL), the main carrier of plasma cholesterol, consists of a hydrophobic core and a surface monolayer of polar lipids and Apolipoprotein-B (ApoB). Oxidative stress and the consequent formation of free radicals lead to the peroxidation of ApoB. Malondialdehyde (MDA) has been identified as one of the major lipid peroxidation products of LDL, thus playing an important role in the LDL oxidation.

The Biomedica MDA ox-LDL ELISA specifically detects MDA-modified Apo B in human serum and plasma.

Click here for MSDS
Click here for PRODUCT LEAFLET 

Back to top